首頁 > 市場調查報告書 > 醫療設備

電子醫療設備

北美神經刺激設備市場預測至 2030 年 - 區域分析 - 按產品、應用和最終用戶

市場調查報告書

商品編碼

1494499

北美神經刺激設備市場預測至 2030 年 - 區域分析 - 按產品、應用和最終用戶

North America Neurostimulation Devices Market Forecast to 2030 - Regional Analysis - by Product, Application, and End User

出版日期: 2024年04月05日 | 出版商:

The Insight Partners | 英文 85 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年北美神經刺激設備市值為24.2264億美元，預計2030年將達到500080萬美元；預計2022年至2030年複合年成長率為9.5%。

神經系統疾病盛行率的增加推動了北美神經刺激設備市場的發展

老年族群是神經系統疾病的易感族群。影響老年人的常見神經系統疾病有神經病變、帕金森氏症、阿茲海默症、肌張力失調等。根據美國國立衛生研究院 (NIH) 的數據，世界人口的 8.5%（即約 6.17 億人）年齡在 65 歲及以上。美國和加拿大等國家與老年人口成長相關的運動障礙和精神疾病盛行率很高。根據帕金森基金會的數據，帕金森症狀在平均 60 歲的人群中很常見。世界衛生組織 (WHO) 指出，癲癇是一種引起癲癇發作的神經系統疾病，影響全球 5,000 萬人。根據美國神經學學會的數據，中風是美國第三大死因，其次是阿茲海默症，是第六大死因。來自同一來源的統計數據顯示，近100萬美國人受到帕金森氏症的影響，每年至少報告6萬例新病例。神經系統疾病的發生率不斷上升，加上憂鬱症和慢性疼痛等與生活方式相關的疾病，導致擴大採用先進技術產品。據世界衛生組織稱，神經疾病佔全球疾病負擔的 6.3%。此外，根據同一消息來源，這些疾病是世界各地死亡的主要原因之一。在已開發國家，其死亡人數佔 13.2%，在低收入和中等收入國家，則佔 16.8%。高死亡率和疾病負擔使得臨床迫切需要整合長期解決方案。此外，人們越來越認知到神經系統疾病的巨大負擔，增加了對神經刺激器作為治療方法的需求。因此，容易患神經系統疾病的老年人口不斷增加，疾病盛行率不斷增加，以及人們對神經系統疾病巨大負擔的認知不斷提高，推動了神經刺激設備市場的成長。

北美神經刺激設備市場概況

北美神經刺激設備市場分為美國、加拿大和墨西哥。由於神經系統疾病的日益普及、研發支出的高額、美國食品藥物管理局（FDA）的產品批准以及技術的進步，預計北美將在全球神經刺激設備市場中佔據重要佔有率。易患神經系統疾病的老年人口不斷增加，預計將在預測期內為該地區的市場成長提供利潤豐厚的機會。此外，政府為解決人們對腦部疾病日益成長的擔憂而提供的越來越多的支持預計將推動該地區的市場成長。在美國，神經血管疾病的發生率正在顯著上升，是全國主要死亡原因之一。帕金森氏症 (PD) 等神經系統疾病發病率的上升、人們對神經系統疾病的認知不斷提高以及對開發經顱刺激器的投資不斷增加，是推動美國整體神經刺激設備市場的主要因素。據觀察，深部腦部刺激（DBS）設備可以有效控制與帕金森氏症相關的震顫。低多巴胺讀數和其他遺傳因素是帕金森氏症的主要原因。

北美神經刺激設備市場收入及 2030 年預測（百萬美元）

北美神經刺激設備市場細分

北美神經刺激設備市場根據產品、應用、最終用戶和國家進行細分。

根據產品，北美神經刺激設備市場分為脊髓刺激器、深部腦部刺激器、薦神經刺激器、迷走神經刺激器等。 2022 年，脊髓刺激器細分市場佔據最大的市場。

從應用來看，北美神經刺激設備市場分為疼痛管理、癲癇、失禁、巴金森氏症等。 2022 年，疼痛管理領域佔據最大的市場。

依最終用戶分類，北美神經刺激設備市場分為醫院、專科診所等。 2022 年，醫院細分市場佔據最大的市場佔有率。

根據國家/地區，北美神經刺激設備市場分為美國、加拿大和墨西哥。 2022 年，美國在北美神經刺激設備市場佔有率中佔據主導地位。

Medtronic Plc、Boston Scientific Corp、Abbott Laboratories、Nevro Corp、LivaNova Plc、Synapse Biomedical Inc、Nalu Medical Inc、ElectroCore Inc、MicroTransponder Inc 和 Mainstay Medical 是北美神經刺激設備市場上的一些領先公司。

Geriatric population is susceptible to neurological diseases. Common neurological disorders affecting older people are neuropathy, Parkinson's disease, Alzheimer's disease, dystonia, and others. As per the National Institutes of Health (NIH), 8.5% of the world's population (i.e., around 617 million people) is aged 65 years and above. Countries such as the US and Canada have high prevalence rates of movement disorders and psychiatric disorders associated with growing geriatric populations. According to the Parkinson's Foundation, Parkinson's symptoms are common at an average age of 60. The Canadian Psychological Association states that obsessive-compulsive disorder (OCD) affects about 2% of the population in Canada. The World Health Organization (WHO) states that epilepsy is a seizure-causing neurological disorder that affects 50 million people worldwide. As per the American Academy of Neurology, stroke is the third leading cause of death in the US, followed by Alzheimer's as the sixth leading cause of death. Statistics from the same source show that nearly one million Americans are affected by Parkinson's, and at least 60,000 new cases are reported annually. The growing incidence of neurological diseases coupled with lifestyle-related disorders such as depression and chronic pain leads to the increasing adoption of technologically advanced products. According to the WHO, nervous disorders contribute to 6.3% of the global disease burden. Also, according to the same source, the disorders are one of the leading causes of deaths across the world. They cause 13.2% of deaths in developed countries and 16.8% in low- and middle-income countries. High mortality and disease burden necessitate the clinical urgency for integrating long-term solutions. Furthermore, growing awareness regarding the tremendous burden of neurological disorders has increased the demand for neurostimulators as a therapy. Therefore, the growing geriatric population prone to neurological diseases, increasing prevalence of the diseases, and rising awareness regarding the tremendous burden of neurological disorders drive the neurostimulation devices market growth.

North America Neurostimulation Devices Market Overview

The North America neurostimulation devices market is segmented into the US, Canada, and Mexico. North America is expected to hold a significant share of the global neurostimulation devices market owing to the growing prevalence of neurological diseases, high spending on research and development, product approvals by the US Food and Drug Administration (FDA), and technological advances. The rising geriatric population prone to neurological diseases is expected to offer lucrative opportunities for market growth in the region during the forecast period. Further, the growing support from the government to address the rising concerns about brain diseases is expected to boost market growth in the region. In the US, the incidence of neurovascular diseases is rising significantly, and it is among the leading causes of death across the country. Rising incidence of neurological diseases such as Parkinson's disease (PD), increasing awareness about neurological disorders, and growing investments in developing transcranial stimulators are among the main factors driving the overall neurostimulation devices market in the US. Deep brain stimulation (DBS) devices have been observed to control the tremors associated with Parkinson's disease effectively. Low dopamine readings and other genetic factors are among the main causes of Parkinson's disease.

North America Neurostimulation Devices Market Revenue and Forecast to 2030 (US$ Million)

North America Neurostimulation Devices Market Segmentation

The North America neurostimulation devices market is segmented based on product, application, end user, and country.

Based on product, the North America neurostimulation devices market is segmented into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and others. The spinal cord stimulator segment held the largest market share in 2022.

In terms of application, the North America neurostimulation devices market is categorized into pain management, epilepsy, urinary and fecal incontinence, Parkinson's disease, and others. The pain management segment held the largest market share in 2022.

By end user, the North America neurostimulation devices market is segmented into hospitals, specialty clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the North America neurostimulation devices market is segmented into the US, Canada, and Mexico. The US dominated the North America neurostimulation devices market share in 2022.

Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, Nevro Corp, LivaNova Plc, Synapse Biomedical Inc, Nalu Medical Inc, ElectroCore Inc, MicroTransponder Inc, and Mainstay Medical are some of the leading companies operating in the North America neurostimulation devices market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Neurostimulation Devices Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Prevalence of Neurological Disorders
- 4.1.2 Rising Cases of Spinal Cord Injury
4.2 Market Restraints
- 4.2.1 Lack of Expert Professionals
4.3 Market Opportunities
- 4.3.1 Growing Advances and Approvals for Neurostimulation Devices
4.4 Future Trends
- 4.4.1 Rising Demand for Noninvasive Treatment
4.5 Impact Analysis

5. Neurostimulation Devices Market - North America Market Analysis

5.1 North America Neurostimulation Devices Market Revenue (US$ Mn), 2022 - 2030

6. North America Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

6.1 Overview
6.2 North America Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Spinal Cord Stimulator
- 6.3.1 Overview
- 6.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Deep Brain Stimulator
- 6.4.1 Overview
- 6.4.2 Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Sacral Nerve Stimulator
- 6.5.1 Overview
- 6.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Vagus Nerve Stimulator
- 6.6.1 Overview
- 6.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
- 6.7.1 Overview
- 6.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

7.1 Overview
7.2 North America Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Pain Management
- 7.3.1 Overview
- 7.3.2 Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Epilepsy
- 7.4.1 Overview
- 7.4.2 Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Urinary and Fecal Incontinence
- 7.5.1 Overview
- 7.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Parkinson's Disease
- 7.6.1 Overview
- 7.6.2 Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

8.1 Overview
8.2 North America Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Hospitals: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Specialty Clinics
- 8.4.1 Overview
- 8.4.2 Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Neurostimulation Devices Market - Revenue and Forecast to 2030 - Country Analysis

9.1 North America: Neurostimulation Devices Market
- 9.1.1 Overview
- 9.1.2 North America: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  - 9.1.2.1 US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.2 US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.2.1 US: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.2.2 US: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.2.3 US: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.3 Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.4 Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.4.1 Canada: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.4.2 Canada: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.4.3 Canada: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.5 Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.6 Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.6.1 Mexico: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.6.2 Mexico: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.6.3 Mexico: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

10. Neurostimulation Devices Market-Industry Landscape

10.1 Overview
10.2 Organic Developments
- 10.2.1 Overview
10.3 Inorganic Developments
- 10.3.1 Overview

11. Company Profiles

11.1 Medtronic Plc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Boston Scientific Corp
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Abbott Laboratories
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Nevro Corp
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 LivaNova Plc
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Synapse Biomedical Inc.
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Nalu Medical, Inc
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 ElectroCore Inc
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 MicroTransponder Inc.
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 Mainstay Medical
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments

12. Appendix

12.1 About Us
12.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Neurostimulation Devices Market Segmentation
Table 2. US Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 3. US Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 4. US Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 5. Canada Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 6. Canada Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 7. Canada Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. Mexico Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. Mexico Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. Mexico Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 11. Organic Developments Done by Companies
Table 12. Inorganic Developments Done by Companies
Table 13. Glossary of Terms, Neurostimulation Devices Market

List Of Figures

Figure 1. Neurostimulation Devices Market Segmentation, By Country
Figure 2. Neurostimulation Devices Market: Key Industry Dynamics
Figure 3. Neurostimulation Devices Market: Impact Analysis of Drivers and Restraints
Figure 4. North America Neurostimulation Devices Market Revenue (US$ Mn), 2020 - 2030
Figure 5. North America Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. North America Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. North America Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
Figure 18. Hospitals & Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. North America: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)
Figure 22. North America: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
Figure 23. US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)